| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 11/15/2006 | EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3 |
| 11/15/2006 | EP1720553A1 Pyrimidine compounds as purine receptor antagonist |
| 11/15/2006 | EP1562907B1 Pyridine derivatives as cb2 receptor modulators |
| 11/15/2006 | EP1539746B1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 11/15/2006 | EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 11/15/2006 | EP1324991B1 Compounds useful in the treatment of inflammatory diseases |
| 11/15/2006 | EP0968206B1 N-heterocyclic derivatives as nos inhibitors |
| 11/15/2006 | CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 11/15/2006 | CN1863799A Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 11/15/2006 | CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 11/15/2006 | CN1863790A Therapeutic agents useful for treating pain |
| 11/15/2006 | CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels |
| 11/15/2006 | CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 11/15/2006 | CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 11/15/2006 | CN1863778A Compounds and methods for treating dyslipidemia |
| 11/15/2006 | CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent |
| 11/15/2006 | CN1863530A (3,4-phenyl)piperidin-3-yl- phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/15/2006 | CN1863528A Indoles and azaindoles as antiviral agents |
| 11/15/2006 | CN1863459A 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action |
| 11/15/2006 | CN1284780C 8'4-'3-(5-fluoro-1H-indol-3-yl)propyl!-1-piperazinyl!-2-methyl-2H-1,4-benzoxazin -3(4H)-one methanesulfonate with high affinity for the dopamine D2 receptor and the seotonin reuptake site |
| 11/14/2006 | US7135575 P38 inhibitors and methods of use thereof |
| 11/14/2006 | US7135495 Indole derivatives |
| 11/14/2006 | US7135490 Method for the treatment of glomerulonephritis |
| 11/14/2006 | US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 11/14/2006 | US7135484 Azabicyclic compounds are central nervous system active agents |
| 11/14/2006 | US7135473 Cyclic diamine compound with condensed-ring groups |
| 11/14/2006 | US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers |
| 11/14/2006 | US7135469 Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors |
| 11/14/2006 | US7135468 Antibacterial compounds |
| 11/14/2006 | US7135467 HIV integrase inhibitors |
| 11/14/2006 | CA2274669C 1,5-benzodiazepine derivatives |
| 11/14/2006 | CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 11/14/2006 | CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 11/12/2006 | CA2546392A1 Phenylpyridinylpiperazine derivatives, a process for their preparation and pharmaceutical compositions containing them |
| 11/12/2006 | CA2546387A1 Phenyl-pyridinyl-piperazine derivatives, process for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 11/09/2006 | WO2006117760A1 Adrenergic receptor antagonists |
| 11/09/2006 | WO2006117653A1 Azole-based phosphodiesterase inhibitors |
| 11/09/2006 | WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 11/09/2006 | WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor |
| 11/09/2006 | WO2006117211A2 Urea derivatives methods for their manufacture and uses thereof |
| 11/09/2006 | WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 11/09/2006 | WO2006072828A3 Heteroaromatic quinoline compounds and their use as pde10 inhibitors |
| 11/09/2006 | WO2006057945A3 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/09/2006 | WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 11/09/2006 | US20060252932 Isolated bis-linezolid, preparation thereof, and its use as a reference standard |
| 11/09/2006 | US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands |
| 11/09/2006 | US20060252795 Chemokine receptor binding heterocyclic compounds |
| 11/09/2006 | US20060252778 Compounds for the treatment of inflammatory disorders |
| 11/09/2006 | US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 11/09/2006 | US20060252767 Piperazine derivatives and their use as therapeutic agents |
| 11/09/2006 | US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| 11/09/2006 | US20060252764 HIV inhibiting pyrimidines derivatives |
| 11/09/2006 | US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects |
| 11/09/2006 | US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists |
| 11/09/2006 | US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists |
| 11/09/2006 | US20060252741 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists |
| 11/09/2006 | US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 11/09/2006 | US20060252093 Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions |
| 11/09/2006 | CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor |
| 11/09/2006 | CA2606538A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 11/09/2006 | CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 11/09/2006 | CA2605008A1 Urea derivatives, methods for their manufacture, and uses therefor |
| 11/08/2006 | EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 11/08/2006 | EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 11/08/2006 | EP1719761A1 Novel heterocyclic compound |
| 11/08/2006 | EP1718641A2 Benzimidazole derivative and its use as aii receptor antagonist |
| 11/08/2006 | EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists |
| 11/08/2006 | EP1718625A1 Compounds |
| 11/08/2006 | EP1718616A2 Isoquinoline derivatives |
| 11/08/2006 | EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators |
| 11/08/2006 | EP1718608A1 Viral polymerase inhibitors |
| 11/08/2006 | EP1718307A2 Immunosuppressant compounds and compositions |
| 11/08/2006 | EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 11/08/2006 | CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 11/08/2006 | CN1860115A Process for the preparation of chiral propionic acid derivatives |
| 11/08/2006 | CN1860114A Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 11/08/2006 | CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors |
| 11/08/2006 | CN1860107A Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 11/08/2006 | CN1859914A Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 11/08/2006 | CN1283638C Indole-2-formamide compounds as factor Xa inhibitors |
| 11/08/2006 | CN1283626C Substituted benzene derivatives or salts thereof |
| 11/08/2006 | CN1283252C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 11/07/2006 | US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 11/07/2006 | US7132542 Compounds for the treatment of male erectile dysfunction |
| 11/07/2006 | US7132534 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers |
| 11/07/2006 | US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders |
| 11/07/2006 | US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 11/07/2006 | US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 11/07/2006 | US7132432 Antiinflammatory agents; vision defects; autoimmune diseases; hepatitis; cardiovascular disordersl chronic fatigue syndromel chronic ostructive pulmonary disease; congestive heart failure |
| 11/07/2006 | US7132427 Quinazolines and uses thereof |
| 11/07/2006 | US7132425 5-substituted-six-membered heteroaromatic glucokinase activators |
| 11/07/2006 | US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 11/07/2006 | US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 11/07/2006 | US7132420 Aspartic protease inhibitors |
| 11/07/2006 | CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives |
| 11/07/2006 | CA2132132C Process for the preparation of 3-arylbenzofuranones |
| 11/02/2006 | WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors |
| 11/02/2006 | WO2006116614A1 Benzisoxazole piperidine compounds and methods of use thereof |
| 11/02/2006 | WO2006116563A1 Vanilloid receptor ligands and their use in treatments |
| 11/02/2006 | WO2006116526A2 Polymorph form ii of tanaproget |